Related Experiment Video

Updated: May 27, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
19:57

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

The Programme for Global Paediatric Research

Alvin Zipursky

    Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
    |December 2, 2011
    PubMed

    Insights

    Global child health research faces a significant imbalance, with most resources in developed nations despite higher disease burdens in developing countries. The Programme for Global Paediatric Research (PGPR) aims to bridge this gap by fostering collaboration and research for children worldwide.

    Area of Science:

    • Global Health
    • Pediatric Research
    • Health Disparities

    Background:

    • A significant disparity exists between the location of pediatric research resources and the prevalence of childhood diseases.
    • The "10/90 gap" highlights that 90% of global child mortality is linked to conditions receiving only 10% of research funding.
    • This imbalance necessitates a redirection of expertise and funding towards the developing world's child health challenges.

    Discussion:

    • The Programme for Global Paediatric Research (PGPR) was initiated to address the underrepresentation of developing world child health issues in major pediatric research conferences.
    • PGPR has evolved beyond a conference focus to become a platform for education, professional networking, and building global research collaborations.
    • The initiative seeks to stimulate greater interest and investment in pediatric research pertinent to the developing world.

    Key Insights:

    • Addressing the "10/90 gap" in child health research is crucial for global health equity.
    • Collaborative networks are essential for pooling resources and expertise to tackle major childhood diseases.
    • The PGPR model demonstrates a successful strategy for reorienting research focus and funding.

    Outlook:

    • Continued expansion of global networks to enhance collaborative research efforts.
    • Increased investment and resource allocation towards pediatric diseases disproportionately affecting developing nations.
    • Long-term impact on reducing child mortality and morbidity through sustained global research partnerships.

    More Related Videos

    Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure15:18

    Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure

    Published on: July 30, 2009

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)08:46

    A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

    Published on: March 7, 2017

    Related Concept Videos

    Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

    Pharmacokinetics in Pediatric Patients: Drug Excretion

    In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
    Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

    Pharmacokinetics in Pediatric Patients: Drug Metabolism

    In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    Global Regulatory Systems01:28

    Global Regulatory Systems

    Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...